F/m Emerald Life Sciences Innovation ETF (LFSC)
- Net assets$122.5M
- Dividend yield0.00%
- 1-year return+36.59%
- Holdings38
LFSC ETF price chart
LFSC quote & trading statistics
LFSC performance
Annual returns & drawdowns →- YTD+15.59%
- 1 year+36.59%
- 1Y volatility
- 23.21%
- 3Y volatility
- 0.00%
- 3Y Sharpe ratio
- 0.00
Returns include reinvested distributions; 3-, 5- and 10-year figures are annualized.
LFSC top 10 holdings
All holdings →| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | LIVN | LivaNova PLC | 6.92% |
| 2 | CORT | Corcept Therapeutics Incorporated | 6.07% |
| 3 | TVTX | Travere Therapeutics Inc | 5.93% |
| 4 | UMRX | Cogent Biosciences Inc | 5.82% |
| 5 | REPL | Replimune Group Inc | 5.78% |
| 6 | SYRE | Spyre Therapeutics Inc. | 5.48% |
| 7 | GH | Guardant Health Inc | 5.06% |
| 8 | BLLN | BillionToOne, Inc. Class A Common Stock | 4.62% |
| 9 | MANE | Veradermics, Incorporated | 4.17% |
| 10 | UTHR | United Therapeutics Corporation | 3.67% |
The top 10 holdings make up 53.5% of the fund (38 holdings in total). As of October 25, 2026.
About F/m Emerald Life Sciences Innovation ETF
The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund"s investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.
LFSC ETF FAQ
How much money is in LFSC?
F/m Emerald Life Sciences Innovation ETF has about $122.5M in net assets.
What are the top holdings of LFSC?
The largest positions in LFSC are LivaNova PLC (6.92%), Corcept Therapeutics Incorporated (6.07%), Travere Therapeutics Inc (5.93%). The fund holds 38 securities in total.
How has LFSC performed?
LFSC returned +36.59% over the past year, including reinvested distributions.
Does LFSC pay dividends?
LFSC has a dividend yield of 0.00%.
When was LFSC launched?
F/m Emerald Life Sciences Innovation ETF began trading on October 30, 2024.